Associate

• Nov 2022 - Present

Associate - Mass. bar admission pending

• Sep 2022 - Nov 2022

Senior Editor

• Jun 2021 - May 2022

Associate Editor

• Jun 2020 - Jun 2021

Law Student

• Sep 2019 - May 2022

Prisoners' Rights Clinic Student Attorney (Rule 3:03 Certified)

• Sep 2021 - Dec 2021

Professional Responsibility Teaching Assistant

• Feb 2021 - May 2021

Legal Intern

• May 2021 - Aug 2021

Conducted legal research, drafted agreements, created compliance training, and performed soft intellectual property, regulatory, and tax work. Conducted legal research, drafted agreements, created compliance training, and performed soft intellectual property, regulatory, and tax work.

Judicial Intern

• Nov 2020 - Feb 2021

Conducted legal research and writing, including bench memos and draft judicial opinions for two cases challenging the Government's final antidumping and countervailing duty determinations. Conducted legal research and writing, including bench memos and draft judicial opinions for two cases challenging the Government's final antidumping and countervailing duty determinations.

Judicial Intern

• May 2020 - Oct 2020

Performed extensive legal research for both the Business Litigation and Criminal Law Sessions. Drafted bench memos, proofread final opinions, and attended court sessions daily during the global pandemic. Performed extensive legal research for both the Business Litigation and Criminal Law Sessions. Drafted bench memos, proofread final opinions, and attended court sessions daily during the global pandemic.

Director, Global Trade and Controlled Substances Compliance

• Jan 2019 - Sep 2019

Director, Global Trade Compliance, Controlled Substances Compliance, and Global Brand Protection

• 2015 - Jan 2019

Established a global trade compliance framework and created the integration plans for the Baxalta and Shire acquisitions. Restructured policies in light of a holistic review of global classifications. Conducted a duty payments review resulting in savings of $7 Million. Created the anti-boycott, embargoed/sanctioned country compliance program, and deemed export compliance programs, performing all licensing in-house. Directly led communication plans with domestic and foreign government agencies. Collaborated extensively with counsel. Led the global controlled substance compliance strategy for amphetamine stimulant sales of over $2.5 Billion that included supervising the development of global and national compliance strategies, overseeing the annual quota approval process, licensing, site inspections by law enforcement, and monitoring for suspicious sale and shipping patterns. Built the brand protection function by leading a cross-functional, global team tasked with mitigating the risks of drug counterfeiting, tampering, diversion, and theft. Performed the first holistic review of brand protection risk and developed decision matrices based on those risks. Tested new technologies for packaging and digital fingerprinting. Led investigative efforts in high-risk markets and collaborated with local law enforcement and regulatory agencies. Show less

Director, Customs & Trade Compliance

• May 2004 - 2015

Created from scratch a centralized trade compliance program for a $4 Billion generic pharmaceutical and medical device company. Transformed trade compliance from a cost into a profit center in a primarily duty-free industry through use of Preferential Trade Agreements. • Crafted an innovative drug launch strategy through the establishment of a Foreign Trade Zone. • Performed detailed valuation reviews for Customs purposes with the Tax Department. Reconciled third party sourcing agreements to customs entries for milestone payments, royalty payments, and assists. • Developed and delivered topic specific training for over 1,000+ global employees in over 100 classes. • Created and led a multi-functional global team that directed the US Customs-Trade Partnership Against Terrorism Program, Canada’s Partners in Protection, and applicable Authorized Economic Operator programs. Validated and revalidated with Tier 3, the highest program rating. • Established a Free Trade Agreement compliance program for nearly 80% of duty-free imports to avoid port taxes and reduce duties paid by affiliates, saving $1.6 Million annually. • Designed an export compliance plan that included in-house export filing, restricted party screening, licensing, and auditing. Licensed and monitored sales to Iran and Syria. Show less

Supervisor, Device Accounting

• May 2003 - May 2004

Conducted the transfer pricing analysis required by the Abbott Tax Department for 600+ products, valued at over $450 million. Consolidated $1 billion of actual and plan reporting for ten global manufacturing sites. Managed the entity planning and consolidation process.

Senior Financial Analyst

• Dec 1999 - May 2003

Consolidated actual and plan reporting for global manufacturing sites and divisional office support. Created annual standards and plan packages for senior management. Coordinated monthly variance reporting.